Lexpos News

MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) Drug Alert Number: EL(25)A/48 Date issued: 11 November 2025 Sun Pharma UK Limited are recalling the batches of tablets specified in the table as a precautionary measure due to failing dissolution test results reported during ongoing stability studies. DMRC reference number: DMRC [...]

The post MHRA Class 3 Medicines Recall: Atorvastatin 20mg and 80mg Film-coated Tablets (Sun Pharmaceutical Industries Limited) appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA) Drug Alert Number: EL(25)A/47 Date issued: 10 November 2025 Zambon SpA is recalling an affected batch as a precautionary measure due to out of specification results for unknown impurities during ongoing stability testing. DMRC reference number: DMRC – 35367036 Marketing Authorisation Holder: Zambon SpA Medicine [...]

The post MHRA Class 3 Medicines Recall: Emylif 50mg orodispersible film (Zambon SpA) appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has issued a medicine supply notification for the following products: Propranolol 80mg modified release capsules Propranolol 160mg modified release capsules MSN/2025/059 Tier 2 – medium impact Date of issue: 10/11/2025 Propranolol 80mg modified release capsules are out of stock until early March 2026. Propranolol 160mg modified release [...]

The post Medicine Supply Notification: Propranolol 80mg and 160mg modified release capsules appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined January, August and October 2025 reimbursement prices for the following products to reflect an increase in their NHS list prices. To avoid pharmacy owners dispensing these products at a loss, DHSC has [...]

The post Retrospective reimbursement prices for January, August and October 2025 appeared first on Community Pharmacy England.

Photo credit: parliamentlive.tv Pharmacies’ ability to manage medicines shortages is constrained by cashflow and reimbursement pressures, with reforms to allow pharmacists greater flexibility to make substitutions sorely needed, Community Pharmacy England has told a Parliamentary inquiry. Dr. James Davies, Director of Research and Insights at Community Pharmacy England, gave oral evidence to the House of [...]

The post Reimbursement pressures and lack of flexibility in dispensing is exacerbating medicines supply issues, warns Community Pharmacy England appeared first on Community Pharmacy England.